Thanks for sharing. I liked this part of the interview:
"we've got a really exciting six months ahead of us with with a possible FDA approval in Q1 of 2025. Uh, and so, you know, we see that with increasing revenues and increasing product registrations, that that's going to be a real correction to our share price and our market cap in the coming months."
Ann: Outstanding 98.6% Success Rate in Striate Implant Study, page-29
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.0¢ |
Change
-0.010(1.59%) |
Mkt cap ! $145.8M | |||
| Open | High | Low | Value | Volume |
| 64.5¢ | 66.0¢ | 61.0¢ | $571.5K | 910.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5198 | 62.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 63.0¢ | 16428 | 4 |
View Market Depth
| Last trade - 15.24pm 07/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |